JP2025503483A5 - - Google Patents
Info
- Publication number
- JP2025503483A5 JP2025503483A5 JP2024537890A JP2024537890A JP2025503483A5 JP 2025503483 A5 JP2025503483 A5 JP 2025503483A5 JP 2024537890 A JP2024537890 A JP 2024537890A JP 2024537890 A JP2024537890 A JP 2024537890A JP 2025503483 A5 JP2025503483 A5 JP 2025503483A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- cfi
- formulation according
- formulation
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163293013P | 2021-12-22 | 2021-12-22 | |
| US63/293,013 | 2021-12-22 | ||
| PCT/US2022/082179 WO2023122691A1 (en) | 2021-12-22 | 2022-12-21 | Complement factor-i formulations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025503483A JP2025503483A (ja) | 2025-02-04 |
| JP2025503483A5 true JP2025503483A5 (enExample) | 2026-01-06 |
Family
ID=85172701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024537890A Pending JP2025503483A (ja) | 2021-12-22 | 2022-12-21 | 補体因子－ｉ製剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250009855A1 (enExample) |
| EP (1) | EP4452321A1 (enExample) |
| JP (1) | JP2025503483A (enExample) |
| KR (1) | KR20240124950A (enExample) |
| CN (1) | CN118450906A (enExample) |
| AU (1) | AU2022420007A1 (enExample) |
| CA (1) | CA3241714A1 (enExample) |
| IL (1) | IL313777A (enExample) |
| MX (1) | MX2024007731A (enExample) |
| WO (1) | WO2023122691A1 (enExample) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201821082D0 (en) * | 2018-12-21 | 2019-02-06 | Gyroscope Therapeutics Ltd | Combination of complement factors i and h, and vector encoding thereof |
| WO2021081348A1 (en) * | 2019-10-23 | 2021-04-29 | Gemini Therapeutics Inc. | Methods for treating patients having cfi mutations with recombinant cfi proteins |
| CA3182800A1 (en) * | 2020-06-14 | 2021-12-23 | Vertex Pharmaceuticals Inc. | Complement factor i-related compositions and methods |
-
2022
- 2022-12-21 IL IL313777A patent/IL313777A/en unknown
- 2022-12-21 EP EP22854364.1A patent/EP4452321A1/en active Pending
- 2022-12-21 WO PCT/US2022/082179 patent/WO2023122691A1/en not_active Ceased
- 2022-12-21 CA CA3241714A patent/CA3241714A1/en active Pending
- 2022-12-21 MX MX2024007731A patent/MX2024007731A/es unknown
- 2022-12-21 JP JP2024537890A patent/JP2025503483A/ja active Pending
- 2022-12-21 AU AU2022420007A patent/AU2022420007A1/en active Pending
- 2022-12-21 KR KR1020247022975A patent/KR20240124950A/ko active Pending
- 2022-12-21 CN CN202280084962.2A patent/CN118450906A/zh active Pending
-
2024
- 2024-06-21 US US18/750,927 patent/US20250009855A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230047111A1 (en) | Pharmaceutical formulations of tnf-alpha antibodies | |
| JP7080263B2 (ja) | 高濃度の抗ｖｅｇｆ抗体を含有する安定状態のタンパク質溶液製剤 | |
| EP1409018B1 (en) | Stable lyophilized pharmaceutical formulation the igg antibody daclizumab | |
| JP5873854B2 (ja) | 凍結乾燥された治療用ペプチボディ製剤 | |
| JP4353544B2 (ja) | アミリン作動薬ペプチド用製剤 | |
| EP2385825B1 (en) | Factor viii formulations | |
| US12053502B2 (en) | Daptomycin formulations | |
| JP3530300B2 (ja) | 安定なトランスグルタミナーゼ製剤およびそれらを製造する方法 | |
| US20100069292A1 (en) | Insulin with a basal release profile | |
| JP2018119006A (ja) | 持続型インスリン分泌性ペプチド結合体の液状製剤 | |
| EP3295952B1 (en) | Pharmaceutical formulation comprising glp-1 analogue and preparation method thereof | |
| JP2003522735A (ja) | Ｉｌ−１１に関する組成物 | |
| KR20210106476A (ko) | 고농도의 항-vegf 항체를 함유하는 단백질 용액 제형 | |
| EP1631305A2 (en) | Sincalide formulations | |
| CN104826094A (zh) | 包含增效比例的干扰素γ和α的稳定的制剂 | |
| US20260055163A1 (en) | Formulations comprising actriia protein variants | |
| JP2025503483A5 (enExample) | ||
| JP6244079B2 (ja) | 乾燥トランスグルタミナーゼ組成物 | |
| WO2019047812A1 (zh) | 多西他赛共缀物的药物组合物及制备方法 | |
| KR102945666B1 (ko) | 인플릭시맵 및 히알루로니다제를 포함하는 피하투여용 약제학적 제제 | |
| EA026073B1 (ru) | Состав бычьего гранулоцитарного колониестимулирующего фактора и способ лечения с его использованием | |
| WO2018181876A1 (ja) | 水性製剤及び注射器入り水性製剤、並びに、抗体タンパク脱凝集剤及び抗体タンパク脱凝集方法 | |
| KR20260047537A (ko) | 인플릭시맵 및 히알루로니다제를 포함하는 피하투여용 약제학적 제제 | |
| JP2025072464A (ja) | 改善された凍結乾燥製剤 | |
| JP2009149684A (ja) | アミリン作動薬ペプチド用製剤 |